CVS Health Corporation
CVS
$73.15
$1.011.40%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -42.32% | 59.84% | -19.65% | -96.15% | -6.89% |
| Total Depreciation and Amortization | 1.74% | 1.41% | 1.15% | 3.02% | 4.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 100.00% | 384.06% | -335.53% | 543.33% | -95.30% |
| Change in Net Operating Assets | -291.93% | -47.56% | 93.48% | -225.00% | -94.15% |
| Cash from Operations | -38.59% | -7.08% | 170.56% | -127.43% | -47.71% |
| Capital Expenditure | 4.86% | -5.39% | 15.70% | -22.94% | -7.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -147.92% | 20.00% | 91.67% | 33.33% | 99.49% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 68.26% | 100.07% | 209.48% | -1,181.25% | -140.15% |
| Cash from Investing | 36.98% | 63.61% | 55.96% | -334.11% | 84.32% |
| Total Debt Issued | -62.25% | -- | 2,036.50% | 160.00% | -77.71% |
| Total Debt Repaid | 483.56% | -8,800.00% | -609.95% | -55.12% | 96.59% |
| Issuance of Common Stock | 88.00% | -29.06% | -45.71% | -6.56% | 4.17% |
| Repurchase of Common Stock | 19.72% | 99.64% | 20.00% | 0.00% | -7.58% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.93% | 0.00% | -7.57% | -7.45% | -7.92% |
| Other Financing Activities | -833.33% | 30.30% | 433.33% | 108.99% | -57.14% |
| Cash from Financing | -35.47% | -90.06% | 144.34% | 41.12% | -65.55% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -38.11% | -7.59% | 135.96% | -655.32% | 427.66% |